Compare ELDN & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELDN | PCYO |
|---|---|---|
| Founded | 2004 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.8M | 249.5M |
| IPO Year | 2014 | 1995 |
| Metric | ELDN | PCYO |
|---|---|---|
| Price | $3.98 | $10.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 60.7K |
| Earning Date | 05-12-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.67 | 12.50 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $1,227,787.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.21 |
| Revenue Growth | N/A | ★ 171.54 |
| 52 Week Low | $1.35 | $9.65 |
| 52 Week High | $4.60 | $12.44 |
| Indicator | ELDN | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 46.50 |
| Support Level | $3.44 | $9.77 |
| Resistance Level | $4.09 | $11.05 |
| Average True Range (ATR) | 0.28 | 0.37 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 53.68 | 47.13 |
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.